02/12/2026 | Press release | Distributed by Public on 02/12/2026 13:00
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Investment Company Act file number 811-22436
Date of fiscal year end: June 30
Date of reporting period: July 1, 2025 - December 31, 2025
ERShares Global Entrepreneurs
ENTIX
: Institutional Class
Semi-Annual Shareholder Report - December 31, 2025
This semi-annual shareholder report contains important information about the ERShares Global Entrepreneurs (the "Fund") for the period of July 1, 2025, to December 31, 2025. You can find additional information about the Fund at https://entrepreneurshares.com/investor-resources/. You can also request this information by contacting us at (877) 271-8811.
(based on a hypothetical $10,000 investment)
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
Institutional Class
|
$50
|
0.98%
|
Sector Weightings (% of net assets)
|
Value
|
Value
|
|
Consumer Staples
|
0.6%
|
|
Energy
|
1.1%
|
|
Utilities
|
1.7%
|
|
Partnership Shares
|
1.8%
|
|
Materials
|
3.3%
|
|
Industrial
|
5.6%
|
|
Money Market Fund
|
7.0%
|
|
Health Care
|
7.2%
|
|
Financials
|
7.5%
|
|
Consumer Discretionary
|
7.8%
|
|
Communications
|
17.8%
|
|
Technology
|
38.6%
|
|
Total Net Assets
|
$46,295,330
|
|
# of Portfolio Holdings
|
57
|
|
Portfolio Turnover Rate
|
22%
|
|
Investment Advisory Fees (Net of fees waived)
|
$146,925
|
ERShares Global Entrepreneurs
ENTIX
214S-ENTIX-25
Semi-Annual Shareholder Report - December 31, 2025
If you wish to view additional information about the Fund; including but not limited to its prospectus, holdings, financial information, and proxy information, please visit https://entrepreneurshares.com/investor-resources/.
P.O. Box 588
Portland, ME 04112
(877) 271-8811
|
(a)
|
Included as part of financial statements filed under Item 7(a).
|
|
(b)
|
Not applicable.
|
|
(b)
|
Included as part of financial statements filed under Item 7(a).
|
EntrepreneurShares Series Trust
|
By
|
/s/ Dr. Joel M. Shulman
|
|
|
Dr. Joel M. Shulman, Principal Executive Officer and Principal Financial Officer
|
||
|
Date
|
February 12, 2026
|
|
|
By
|
/s/ Dr. Joel M. Shulman
|
|
|
Dr. Joel M. Shulman, Principal Executive Officer and Principal Financial Officer
|
||
|
Date
|
February 12, 2026
|
|